Abstract:Background: Epidemiological and cytological studies have found a potential protective function of Vitamin D3 in colitis-associated colorectal cancer (CAC). In this study, we aim to decipher this effect in an azoxymethane (AOM) and dextran sulfate sodium (DSS) induced CAC mouse model and explore the underlying mechanism primarily focusing on the β-catenin signaling pathway. Methods: In vitro, colon cancer cell line SW480 were treated with 1,25(OH)2D3 at different concentrations (1, 10, 50 and 100nmol/L) for 24, 48 and 72h and then quantified for proliferation. Transcriptional activity and the protein level of β-catenin were determined in SW480 cells both nontreated (control) and treated with 100nmol/L 1,25(OH)2D3 for 48h. Same assay was applied to SW480 cells with FOXM1 and nVDR siRNA knockdowns separately. In animal experiment, C57BL/6 mice were divided into 6 groups. Group 1 was the naïve control given only saline. Group 2 to 6 were given AOM (12.5mg/kg) by intraperitoneal injection and 2.5% DSS by gastric lavage sequentially to establish CAC model. Group 2 was the model control; Group 3 to 5 received Vitamin D3 at 15, 30, 60IU/g/w before AOM/DSS treatment, while Group 6 (post-dose group) received 60IU/g/w VitD3 5 days after DSS intake. Mice were sacrificed after 14 weeks. Macroscopic and pathologic evaluations were carried out to assess the severity of CAC. The mRNA and protein levels of β-catenin were also detected. Results: The proliferation of SW480 cells was significantly inhibited by 1,25(OH)2D3 both dose-dependently and time-dependently (p<0.05). 1,25(OH)2D3 significantly decreased the transcriptional activity of β-catenin in SW480 cells by promoting the nuclear export of β-catenin (p<0.05) without affecting the mRNA and protein levels of β-catenin, which could be recovered by knocking down either FOXM1 or nVDR. In mice, Vitamin D intervention groups (G4,5,6) showed a lower tumor number and smaller tumor load than model control (G2) (p<0.05). However, there was no significant difference between the high dose group (G5) and post-dose group (G6). In addition, Vitamin D intervention groups presented lower β-catenin mRNA level than model control (p<0.05). The amount of nuclear β-catenin decreased as the VitD3 dose increased. Finally, the protein expression level of β-catenin was much less in the high dose group (G5) than model control (p<0.05). Conclusions: 1,25(OH)2D3 downregulates the transcriptional activity of β-catenin by expelling β-catenin out of nucleus and therefore severely dampens the proliferation of SW480 human colon cancer cells. In mice model, VitD3 treatment successfully inhibits the progression from AOM/DSS-induced colitis to colorectal cancer potentially by downregulating the activity of β-catenin signaling pathway.

Tocotrienol suppresses colitis-associated cancer progression through TLR4 signaling in a mouse model of colorectal cancer

Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer.

P083 the Protective Role of Vitamin D3 on Colitis-Associated Colorectal Cancer in a Mouse Model

Toll-like receptor 3 signaling attenuated colitis-associated cancer development in mice

Tanshinone IIA attenuates AOM/DSS-induced colorectal tumorigenesis in mice via inhibition of intestinal inflammation

Expression of the Novel Adipokine C1qTNF-related Protein 4 (CTRP4) Suppresses Colitis and Colitis-Associated Colorectal Cancer in Mice

Suppression of Transmembrane Tumor Necrosis Factor Alpha Processing by a Specific Antibody Protects Against Colitis-Associated Cancer

Blocking TNF-alpha in Mice Reduces Colorectal Carcinogenesis Associated with Chronic Colitis.

Taurine Attenuates Carcinogenicity in Ulcerative Colitis-Colorectal Cancer Mouse Model

Short-chain fatty acids administration is protective in colitis-associated colorectal cancer development.

Erlotinib suppresses tumorigenesis in a mouse model of colitis-associated cancer

A Nucleotide Analog Prevents Colitis-Associated Cancer via Beta-Catenin Independently of Inflammation and Autophagy

Chemoprevention of Azoxymethane-induced Colon Carcinogenesis by Delta-Tocotrienol.

Supplementation with High or Low Iron Reduces Colitis Severity in an AOM/DSS Mouse Model

Toll-like Receptor 2 Signaling Protects Mice from Tumor Development in a Mouse Model of Colitis-Induced Cancer.

Tea Polysaccharides Inhibit Colitis-Associated Colorectal Cancer Via Interleukin-6/STAT3 Pathway

Sulforaphane Attenuates AOM/DSS-Induced Colorectal Tumorigenesis in Mice via Inhibition of Intestinal Inflammation

Quercetin Suppresses AOM/DSS-Induced Colon Carcinogenesis Through Its Anti-Inflammation Effects in Mice.

Protective Role of Fecal Microbiota Transplantation on Colitis and Colitis-Associated Colon Cancer in Mice Is Associated With Treg Cells

Phycocyanin Ameliorates Colitis-Associated Colorectal Cancer by Regulating the Gut Microbiota and the IL-17 Signaling Pathway

Effect of Lactobacillus fermentum ZS40 on the NF-κB signaling pathway in an azomethane-dextran sulfate sodium-induced colon cancer mouse model